How Cancer Drug Keytruda (Pembrolizumab) Treats Melanoma

FDA approved cancer drug Keytruda (pembrolizumab) is used to treat advanced melanoma skin cancer. In this video, Dr. Stephen Lemon talks about how this immunotherapy treatment works, as well as what types of side effects it may cause patients.

Keytruda was developed by Merck. Dr. Lemon is a medical oncologist who is not affiliated with Merck.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email